Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.05057 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.09088 | 67 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.64802 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.94128 | 65 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.19751 | 68 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.19851 | 68 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.06309 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.21006 | 68 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.02505 | 66 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.87772 | 65 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.03639 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.04011 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.94688 | 65 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.04401 | 67 |